CBC is an active phytocannabinoid found in cannabis. It has modest antinociceptive (pain-blocking) and anti-inflammatory effects in vitro and in vivo.
It may also have mood-boosting properties due to its ability to bind with TRP channels like TRPV1. When activated, these channels release the body’s natural endocannabinoids, Anandamide. This could help elevate your mood without the risks of intoxication.
CBC, or cannabichromene, is one of the most abundant cannabinoids in the cannabis plant, alongside THC and CBD. It was first identified in 1966, and even though research is still in its infancy, CBC’s therapeutic potential is multiplying.
Its anti-inflammatory properties have been demonstrated to work differently than non-steroidal anti-inflammatory drugs (NSAIDs) without side effects. CBC seems to have an anti-inflammatory effect that’s independent of cannabinoid receptors.
Additionally, it has been shown to increase the body’s natural endocannabinoid anandamide. This endocannabinoid has also been found to fight breast cancer, inhibit tumor growth, and stimulate brain cell development.
The anti-inflammatory properties of CBC result from it reacting with various pain-related receptors. These include vanilloid receptor 1 (TRPV1) and transient receptor potential ankyrin 1 (TRPA1).
THC has been linked to many anti-inflammatory benefits, such as helping to reduce pain and inflammation. It also helps to relieve nausea, vomiting, and seizures.
Cannabichromene (CBC) is a non-psychoactive cannabinoid found in hemp plants that bind with different receptors in the body than CBD and THC. These include receptors involved in pain perception and inflammation response.
Buying CBC wholesale is good because it has antiviral, anti-tumor, and bone-growth-stimulating effects. It has been shown to help fight infections and may increase bone density when taken in conjunction with other cannabinoids.
As with all cannabinoids, they should be used in moderation and ideally only at your doctor’s recommendation. It should not be taken in large amounts or by people prone to addiction.
CBD has demonstrated anti-inflammatory properties in multiple experimental models, in vitro and in vivo. The mechanism of this activity has yet to be entirely understood, although it may be related to the activation of several signaling pathways.
CBD inhibited inflammation in newborn mice’s hypoxic-ischemic (HI) brains, reducing expression of IL-6, TNF-a, COX-2, and iNOS. It also reduces brain oxidative stress and excitotoxicity. This activity was suggested to be mediated via CB2 and adenosine A2A receptors.
Moreover, CBD activates PPARg, the endocannabinoid receptor with significant antioxidant and anti-inflammatory effects, through AEA and 2-AG agonist activity. It also prevents amyloid b-induced neuronal death by increasing the level of Wnt/b-catenin.
CBD is a natural product derived from hemp or marijuana plants. It can treat various medical conditions, including epilepsy, arthritis and pain, and insomnia.
Cannabis is not the only plant to produce phytocannabinoids. In addition to tetrahydrocannabinol (THC) and cannabidiol (CBD), other vital compounds include THCV, CBN, and CBG.
While these cannabinoids may not have the psychoactive effects of THC, they provide a range of beneficial medical properties. Several of these compounds have anti-inflammatory and pain-relieving properties.
For example, the phytocannabinoid CBG is effective in the treatment of glaucoma. This is because CBG binds to CB1 and CB2 cannabinoid receptors in the eye.
While research into these other phytocannabinoids is limited, it is clear that they can provide valuable therapeutic benefits for specific conditions. The future of nutraceuticals is exciting as we continue to learn more about these understudied natural medicines.